KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 142 filers reported holding KURA ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 1.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,675,643 | -54.8% | 296,184 | -50.3% | 0.01% | -18.8% |
| Q3 2022 | $8,135,770 | -39.1% | 595,574 | -18.3% | 0.02% | -36.0% |
| Q2 2022 | $13,364,183 | +11.8% | 729,098 | -1.9% | 0.02% | +47.1% |
| Q1 2022 | $11,951,971 | +170.3% | 743,280 | +135.3% | 0.02% | +54.5% |
| Q4 2021 | $4,422,000 | +38.7% | 315,852 | +85.5% | 0.01% | +22.2% |
| Q3 2021 | $3,188,000 | -53.4% | 170,226 | -48.1% | 0.01% | -10.0% |
| Q2 2021 | $6,838,000 | +37.1% | 327,914 | +85.9% | 0.01% | -33.3% |
| Q1 2021 | $4,987,000 | -11.8% | 176,411 | +1.9% | 0.02% | -16.7% |
| Q4 2020 | $5,655,000 | -15.0% | 173,141 | -20.3% | 0.02% | -25.0% |
| Q3 2020 | $6,654,000 | -35.2% | 217,163 | -65.5% | 0.02% | +20.0% |
| Q2 2020 | $10,264,000 | +58.2% | 629,742 | -3.4% | 0.02% | +25.0% |
| Q1 2020 | $6,488,000 | – | 652,110 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |